Hikma Pharmaceuticals (HIK.LSE) Q3 2024 Earnings

Aug 8Confirmed
Q4 2022
Q2 2023
Q1 2024
Q3 2024
0.91
33.82
66.73
99.63

Details

Expected EPS
N/A
Actual EPS
99.63404
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Hikma Pharmaceuticals⁩ (⁦HIK.LSE⁩) has reported earnings of ⁦99.63404⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts